Outcome
    Limited

    HMB for Muscle Strength & Physical Function

    RCTs show benefits concentrated in untrained individuals, older adults, and during caloric restriction; minimal added effect in well-trained, well-fed athletes.

    Overview

    Beta-hydroxy-beta-methylbutyrate is a metabolite of leucine, and its evidence is strikingly age-dependent. In young trained athletes HMB has largely disappointed. In older adults and people losing muscle it looks considerably better. A 2022 Nutrients meta-analysis of HMB and muscle strength in the elderly and a 2025 Archives of Gerontology and Geriatrics meta-analysis in sarcopenia both support benefit in this population.
    The pattern makes biological sense. HMB primary action is anti-catabolic, slowing muscle protein breakdown, which matters most where breakdown is elevated: ageing, bed rest, illness and immobilisation. Effects on strength are modest and more consistent than effects on lean mass, and results are stronger where protein intake is inadequate. HMB is not a substitute for resistance training or adequate protein; it is a supplement to both, most useful when either is hard to achieve.

    How It Works

    Roughly 5 percent of dietary leucine is converted to HMB, so a 3 g supplemental dose corresponds to about 60 g of leucine, far more than diet supplies. Its dominant action is inhibition of muscle protein breakdown, mediated through downregulation of the ubiquitin-proteasome pathway that tags damaged proteins for degradation. It also appears to reduce caspase-mediated apoptosis in muscle tissue, another route by which muscle is lost during illness or disuse.
    HMB additionally stimulates mTOR signalling and so contributes to muscle protein synthesis, though less potently than leucine itself at equivalent anabolic effect. It has been reported to support sarcolemmal integrity via cholesterol synthesis in muscle membranes and to enhance satellite cell proliferation. The anti-catabolic emphasis explains the clinical pattern. In young athletes with low breakdown rates and adequate protein, there is little for HMB to prevent, so effects are small. In sarcopenia, where breakdown is elevated, the same mechanism yields measurable strength preservation.

    Dosing & Protocol

    Three grams per day is the standard dose across essentially the entire literature, usually split into three 1 g doses with meals. There is no evidence that more helps. Two forms exist: calcium HMB, used in most trials, and free acid HMB, which reaches peak plasma levels faster but has not shown better clinical outcomes. Effects accumulate over weeks; allow eight to twelve weeks. Pairing with resistance training and adequate protein produces the most reliable results.

    Protein and training come first

    Around 1.2 to 1.6 g of protein per kg of body weight daily plus resistance training outperforms HMB. Add HMB on top of those, not instead of them.

    Evidence

    Two linked meta-analyses support this pairing: a 2022 Nutrients meta-analysis of HMB and muscle strength in the elderly population, and a 2025 Archives of Gerontology and Geriatrics systematic review and meta-analysis of HMB in patients with sarcopenia. Both report improvement in strength measures in older adults, with more modest and less consistent effects on lean mass. Limitations include small trial sizes, variable co-interventions of protein and exercise, and heterogeneous strength outcome measures.

    Studies linked to this pairing.

    Effect of beta-hydroxy-beta-methylbutyrate (HMB) on muscle strength in the elderly population: a meta-analysis

    Score: 8/10
    2022
    meta_analysis
    n=900

    Prado CM, Orsso CE, Pereira SL +2 more

    HMB produced a small but significant improvement in muscle strength, most evident during bed rest or low baseline function.

    View source

    The effects of beta-hydroxy-beta-methylbutyrate supplementation in patients with sarcopenia: a systematic review and meta-analysis

    Score: 8/10
    2025
    meta_analysis
    n=800

    Gu WT, Zhang LW, Wu FH +1 more

    HMB significantly increased muscle mass but effects on muscle strength and physical performance were small and inconsistent.

    View source

    Safety

    HMB has an unusually clean safety record. Trials lasting up to a year, including in older and clinically unwell populations, have found no adverse effects on liver enzymes, kidney function, lipids or blood glucose at 3 g per day. Side effects are rare and mild, mostly minor gastrointestinal upset. Data in pregnancy, breastfeeding and children are lacking, so it is not recommended there. Long-term use beyond a year has not been systematically studied.

    Unexplained muscle loss needs investigation

    Rapid or unexplained loss of muscle and strength can signal thyroid disease, malignancy, heart failure or malnutrition. Get it assessed rather than supplementing around it.

    Interactions & Conflicts

    HMB has no documented drug interactions and no known pharmacokinetic effects on medications. The conflicts here are about expectations and substitution. The main risk is using HMB in place of the interventions that work better: progressive resistance training and adequate protein intake. In young, well-fed trained athletes the evidence is weak, so spending on HMB there is generally poor value compared with protein and programming.
    Interacts withSeverityMechanismAction
    moderate
    		——
    moderate
    		——
    low
    		——
    low
    		——
    moderate
    		——
    high
    		——

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.